S'abonner

Bloody Diarrhea and Shiga Toxin–Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network - 22/09/21

Doi : 10.1016/j.jpeds.2021.06.048 
Gianluigi Ardissino, MD, PhD 1, , Chiara Vignati, MSc 2, Carla Masia, MSc 2, Valentina Capone, MD 1, Rosaria Colombo, MSc 2, Francesca Tel, MD 3, Laura Daprai, MSc 2, Sara Testa, MD 1, Antonella Dodaro, MSc 2, Fabio Paglialonga, MD 1, Mario Luini, VD 4, 5, Maurizio Brigotti, MD 6, Damiano Picicco, MSc 7, Carlo Baldioli, MD 8, Franca Pagani, MD 9, Rossella Ceruti, BS 10, Paola Tommasi, MD 3, Ilaria Possenti, MD 11, Donata Cresseri, MD 12, Dario Consonni, MD 13, Giovanni Montini, MD 1, 14, Milena Arghittu, MSc 15
on behalf of the

ItalKid-HUS Network

  List of additional members of the ItalKid-HUS Network is available at www.jpeds.com (Appendix).

1 Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milano 
2 Laboratory of Microbiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano 
3 Department of Pediatrics, Vittore Buzzi Children's Hospital, Milano 
4 Lombardia and Emilia Romagna Experimental Zootechnic Institute (IZSLER), Lodi 
5 Institute of Agricultural Biology and Biotechnology, National Research Council, Lodi 
6 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna 
7 ASL 1 Imperiese: Azienda Sanitaria Locale 1 Imperiese - Ospedale di Sanremo, Sanremo 
8 Pediatric Unit, Ospedale Pia Luvini, ASST-Sette Laghi-Università Insubria, Cittiglio 
9 Department of Laboratory Medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia 
10 Department of Laboratory Medicine, Azienda Ospedaliera Carlo Poma, Mantova 
11 Pediatric Unit, Ospedale Infantile C. Arrigo, Alessandria 
12 Nephrology and Dialysis Unit, Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano 
13 Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano 
14 Department of Clinical Sciences and Community Health, University of Milan, Milano 
15 Azienda socio sanitaria territoriale (ASST) Melegnano e della Martesana - Vizzolo Predabissi, Milano, Italy 

Reprint requests: Gianluigi Ardissino, Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via della Commenda 9, 20122 Milano, Italy.Center for HUS Prevention Control and ManagementFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoVia della Commenda 920122 MilanoItaly

Abstract

Objective

To analyze the results of an enhanced laboratory-surveillance protocol for bloody diarrhea aimed at identifying children with Shiga toxin–producing Escherichia coli (STEC) infection early in the course of the disease toward the early identification and management of patients with hemolytic uremic syndrome (HUS).

Study design

The study (2010-2019) involved a referral population of 2.3 million children. Stool samples of patients with bloody diarrhea were screened for Shiga toxin (Stx) genes. Positive patients were rehydrated and monitored for hemoglobinuria until diarrhea resolved or STEC-HUS was diagnosed.

Results

A total of 4767 children were screened; 214 (4.5%) were positive for either Stx1 (29.0%) or Stx2 (45.3%) or both Stx1+2 (25.7%); 34 patients (15.9%) developed STEC-HUS (0.71% of bloody diarrheas). Hemoglobinuria was present in all patients with HUS. Patients with Stx2 alone showed a greater risk of STEC-HUS (23.7% vs 12.7%) and none of the patients with Stx1 alone developed HUS. During the same period of time, 95 other patients were diagnosed STEC-HUS but were not captured by the screening program (26 had nonbloody diarrhea, 11 came from areas not covered by the screening program, and 58 had not been referred to the screening program, although they did meet the inclusion criteria). At HUS presentation, serum creatinine of patients identified by screening was significantly lower compared with that of the remaining patients (median 0.9 vs 1.51 mg/dL).

Conclusions

Nearly 1% of children with bloody diarrhea developed STEC-HUS, and its diagnosis was anticipated by the screening program for Stx. The screening of bloody diarrhea for Stx is recommended, and monitoring patients carrying Stx2 with urine dipstick for hemoglobinuria is suggested to identify the renal complication as early as possible.

Le texte complet de cet article est disponible en PDF.

Keywords : Shiga toxin, hemolytic uremic syndrome, diarrhea, bloody diarrhea, children

Abbreviations : eae, HUS, ipaH, PCR, sCr, STEC, Stx, TMA


Plan


 Financed by an unrestricted research grant from the “Progetto Alice ONLUS. Associazione per la lotta alla SEU.” The funder did not participate in the work. The authors declare no conflicts of interest.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 237

P. 34 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada
  • Simon C. Ling, Hsing-Hua S. Lin, Karen F. Murray, Philip Rosenthal, Douglas Mogul, Norberto Rodriguez-Baez, Sarah Jane Schwarzenberg, Jeffrey Teckman, Kathleen B. Schwarz, Hepatitis B Research Network (HBRN), Hongxia Li, Robert Anders, Hejab Imteyaz, Peter Lee, Kiyoko Oshima, Kim Kafka, Naureen Islam, Shannon M. Riggs, Rosemary A. Nagy, Jacki Cerkoski, Athena Hau, Daniel Cui, Laurie A. Rodgers-Augustyniak, Shirley Montanye, Natasha Feier, Joel Feier, Camille Langlois, Kara L. Cooper, Jay H. Hoofnagle, Averell H. Sherker, Edward Doo, Rebecca J. Torrance, Sherry R. Hall, Frani Averbach, Tamara Haller, Regina Hardison, Stephanie Kelley, Christina M. Lalama, Sharon Lawlor, Manuel Lombardero, Andrew Pelesko, Donna Stoliker, Melissa Weiner, Ella Zadorozny, Qian Zhao
| Article suivant Article suivant
  • Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy
  • Veronica C. Beck, Lori L. Isom, Anne T. Berg

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.